#oncology — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #oncology, aggregated by home.social.
-
Cancer care is changing.
Precision medicine, immunotherapy, AI and earlier detection are reshaping oncology.
Explore the future of cancer research: https://www.newsletter.co.uk/your-world/cancer-at-a-turning-point-how-science-is-changing-the-fight-against-the-disease-9055435
-
Hey, I'm Birk, Co-founder of #CYMANTICMEDICAL an #Irish #Medtech #startup addressing the issue of inadequate sampling during #cancer #biopsies.
We are taking part in the #medtechinnovator #accelerator in #sanfrancisco the world's biggest medtech accelerator. Part of it is a video competition and our video is now online and we need YOU to WATCH, VOTE and SHARE!
About 25% of cancer biopsies are inadequate for a diagnosis and 30% of cancer surgeries are incomplete - meaning they require a repeat procedure weeks after the the first.
This takes a toll on the patients, delays diagnosis and treatment and drives up the cost by 40% to 80% and reducing the hospital throughput while the timing for the patients would be critical.
We address this via automated sample preparation and computer vision to get real time results directly in the procedure room.
Please , watch our video, vote and share:
https://medtechinnovator.org/company-videos-2026/?record=65702
#cancer #surgery #biopsy #startup #Dublin #medtechinnovator #MTI #BRYCK #UCD #neurodivergent #oncology 🖖🤓🤘
www.cymanticmedical.com
-
Hey, I'm Birk, Co-founder of #CYMANTICMEDICAL an #Irish #Medtech #startup addressing the issue of inadequate sampling during #cancer #biopsies.
We are taking part in the #medtechinnovator #accelerator in #sanfrancisco the world's biggest medtech accelerator. Part of it is a video competition and our video is now online and we need YOU to WATCH, VOTE and SHARE!
About 25% of cancer biopsies are inadequate for a diagnosis and 30% of cancer surgeries are incomplete - meaning they require a repeat procedure weeks after the first.
This takes a toll on the patients, delays diagnosis and treatment and drives up the cost by 40% to 80% and reducing the hospital throughput while the timing for the patients would be critical.
We address this via automated sample preparation and computer vision to get real time results directly in the procedure room.
Please , watch our video, vote and share:
https://medtechinnovator.org/company-videos-2026/?record=65702
#cancer #surgery #biopsy #startup #Dublin #medtechinnovator #MTI #BRYCK #UCD #neurodivergent #oncology 🖖🤓🤘
#computervisionwww.cymanticmedical.com
-
Hey, I'm Birk, Co-founder of #CYMANTICMEDICAL an #Irish #Medtech #startup addressing the issue of inadequate sampling during #cancer #biopsies.
We are taking part in the #medtechinnovator #accelerator in #sanfrancisco the world's biggest medtech accelerator. Part of it is a video competition and our video is now online and we need YOU to WATCH, VOTE and SHARE!
About 25% of cancer biopsies are inadequate for a diagnosis and 30% of cancer surgeries are incomplete - meaning they require a repeat procedure weeks after the first.
This takes a toll on the patients, delays diagnosis and treatment and drives up the cost by 40% to 80% and reducing the hospital throughput while the timing for the patients would be critical.
We address this via automated sample preparation and computer vision to get real time results directly in the procedure room.
Please , watch our video, vote and share:
https://medtechinnovator.org/company-videos-2026/?record=65702
#cancer #surgery #biopsy #startup #Dublin #medtechinnovator #MTI #BRYCK #UCD #neurodivergent #oncology 🖖🤓🤘
#computervisionwww.cymanticmedical.com
-
Hey, I'm Birk, Co-founder of #CYMANTICMEDICAL an #Irish #Medtech #startup addressing the issue of inadequate sampling during #cancer #biopsies.
We are taking part in the #medtechinnovator #accelerator in #sanfrancisco the world's biggest medtech accelerator. Part of it is a video competition and our video is now online and we need YOU to WATCH, VOTE and SHARE!
About 25% of cancer biopsies are inadequate for a diagnosis and 30% of cancer surgeries are incomplete - meaning they require a repeat procedure weeks after the first.
This takes a toll on the patients, delays diagnosis and treatment and drives up the cost by 40% to 80% and reducing the hospital throughput while the timing for the patients would be critical.
We address this via automated sample preparation and computer vision to get real time results directly in the procedure room.
Please , watch our video, vote and share:
https://medtechinnovator.org/company-videos-2026/?record=65702
#cancer #surgery #biopsy #startup #Dublin #medtechinnovator #MTI #BRYCK #UCD #neurodivergent #oncology 🖖🤓🤘
#computervisionwww.cymanticmedical.com
-
Hey, I'm Birk, Co-founder of #CYMANTICMEDICAL an #Irish #Medtech #startup addressing the issue of inadequate sampling during #cancer #biopsies.
We are taking part in the #medtechinnovator #accelerator in #sanfrancisco the world's biggest medtech accelerator. Part of it is a video competition and our video is now online and we need YOU to WATCH, VOTE and SHARE!
About 25% of cancer biopsies are inadequate for a diagnosis and 30% of cancer surgeries are incomplete - meaning they require a repeat procedure weeks after the first.
This takes a toll on the patients, delays diagnosis and treatment and drives up the cost by 40% to 80% and reducing the hospital throughput while the timing for the patients would be critical.
We address this via automated sample preparation and computer vision to get real time results directly in the procedure room.
Please , watch our video, vote and share:
https://medtechinnovator.org/company-videos-2026/?record=65702
#cancer #surgery #biopsy #startup #Dublin #medtechinnovator #MTI #BRYCK #UCD #neurodivergent #oncology 🖖🤓🤘
#computervisionwww.cymanticmedical.com
-
UT names Governor’s Chair for Nuclear Medicine to advance targeted cancer therapies | Local News https://www.byteseu.com/2236875/ #Cancer #CancerTreatment #ClinicalMedicine #Health #HealthCare #HealthSciences #Isotope #MedicalSpecialties #MedicalTreatments #Medicine #Nuclear #NuclearMedicine #OakRidgeNationalLaboratory #Oncology #radionuclide #radiopharmaceutical #Research #TargetedTherapy #UndergraduateEducation #UniversityOfTennessee
-
Virtual karyotype (Genetics 🧬)
Virtual karyotype is the digital information reflecting a karyotype, resulting from the analysis of short sequences of DNA from specific loci all over the genome, which are isolated and enumerated. It detects genomic copy number variations at a higher resolution for level than conventional karyotyping or chromosome-based comparative genomic hybridization. The m...